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Inflammatory diseases at epithelial borders
develop from aberrant interactions between
resident cells of the tissue and invading immu-
nocytes. Here, we unraveled basic functions
of epithelial cells and immune cells and the
sequence of their interactions in an inflamma-
tory skin disease. Ubiquitous deficiency of the
IkBa protein (IkbaD/D) as well as concomitant
deletion of Ikba specifically in keratinocytes
and T cells (IkbaK5D/K5D lckD/lckD) resulted in an
inflammatory skin phenotype that involved the
epithelial compartment and depended on the
presence of lymphocytes as well as tumor
necrosis factor and lymphotoxin signaling. In
contrast, mice with selective ablation of Ikba
in keratinocytes or lymphocytes showed
inflammation limited to the dermal compart-
ment or a normal skin phenotype, respectively.
Targeted deletion of RelA from epidermal kera-
tinocytes completely rescued the inflammatory
skin phenotype of IkbaD/D mice. This finding
emphasizes the important role of aberrant
NF-kB activation in both keratinocytes and lym-
phocytes in the development of the observed
inflammatory skin changes.296 Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc.INTRODUCTION
The pathogenesis of inflammatory diseases at the epithe-
lial border such as psoriasis and inflammatory bowel
disease is still unexplained. In psoriasis pathogenesis,
there is an intensive discussion concerning the functional
role of the epithelium and inflammatory cells. Recent
evidence indicates that CD4+ T cells are essential for the
initiation and maintenance of the disease and that cross-
primed CD8+ T cells respond to antigens derived by
keratinocytes (Gudjonsson et al., 2004). In addition, over-
lapping susceptibility loci associated with autoimmunity
define psoriasis as a putative autoimmune disease
(Bowcock and Krueger, 2005). Yet, data from transgenic
mice, such as the rat insulin promoter-glycoprotein (RIP-
GP) mice (Lang et al., 2005), suggest that selective activa-
tion of immune cells alone is not sufficient for initiation of
an autoimmune disease. These findings can be combined
in a model, in which development of an autoimmune
disease requires simultaneous aberrant signaling in the
immune system and the target organ. Psoriasis is a dis-
ease of the skin with a prevalence of approximately 2%
in Caucasian populations. Phenotyping of skin-infiltrating
cells in psoriasis demonstrates the prevalence of Th1 cells
(Ghoreschi et al., 2003). Data from adoptive T cell-transfer
experiments (Wrone-Smith and Nickoloff, 1996) demon-
strate that injection of autologous blood-derived immuno-
cytes, especially CD4+ T cells, into nonlesional human skin
transplanted onto severe combined immunodeficient
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RelA Coordinates Inflammatory Skin Disease in IkBa-Deficient Micemice results in the development of psoriasis in the xeno-
graft. Il-4 therapy of patients with psoriasis improved the
disease and skewed the Th1 response into an anti-inflam-
matory Th2 response (Ghoreschi et al., 2003) suggesting
that aberrant activation of adaptive immunity is critical
for the development of psoriasis. In contrast, the high ther-
apeutic efficacy of topical treatment with anthralin (Law-
rence and Shuster, 1992), which is not known to affect
T cell function, as well as genetic data (Bowcock, 2005),
which do not necessarily link psoriasis-associated gene
regions to ‘‘immune loci,’’ strongly suggests that psoriasis
also relies on abnormal signaling events in keratinocytes
showing a hyperproliferative capacity. The data available
at present can be embraced in a model in which psoriatic
inflammatory skin disease depends on simultaneous
abnormal signaling in both compartments, the keratino-
cytes and the immune cells.
The transcription factor NF-kB is a complex formed by
homodimerization and heterodimerization of the NF-kB
family members p50 (NF-kB1), p52 (NF-kB2), RelA (p65),
RelB, and c-Rel. Stimuli that are capable of activating IkB
kinase (IKK) result in serine phosphorylation, ubiquitina-
tion, and subsequent degradation of IkBa, which allows
translocation of NF-kB to the nucleus (Hayden and Ghosh,
2004; Karin and Ben-Neriah, 2000; Li and Verma, 2002). In
addition to degradation of IkBa, phosphorylation of the
transactivating subunit RelA is an essential regulatory step
for transcriptional activity (Viatour et al., 2005). NF-kB,
most often composed of p50 and RelA, is a crucial media-
tor of inflammatory processes (Karin and Greten, 2005). To
determine whether NF-kB overactivation might be relevant
for the induction of an inflammatory skin disease, we gen-
erated mice with conditional disruption of its cytoplasmic
receptor, Ikba. We found that mice with ubiquitous deletion
of Ikba developed a severe inflammatory skin phenotype
that involved the epithelial compartment. Neither keratino-
cyte- nor T cell-specific deletion of Ikba recapitulated this
phenotype. Exclusively concomitant deletion of Ikba in
keratinocytes and T cells resulted in development of the
inflammatory phenotype observed in mice with ubiquitous
deletion. Finally, this phenotype could be rescued by
additional keratinocyte-specific deletion of Rela, demon-
strating the importance of the NF-kB pathway in keratino-
cyte-T cell crosstalk in skin inflammation.
RESULTS
Aberrant Keratinization, Microabscesses, and
Infiltrating ImmuneCells in the Skin of IkbaD/DMice
To study the consequences of ubiquitous activation of
NF-kB for skin homeostasis, we crossed mice carrying
a LoxP-site-containing (floxed) Ikba allele with Deleter-
Cre mice (Schwenk et al., 1995). We used this loss-of-
function approach because it mimics the natural events
of NF-kB activation observed after natural stimulation
more closely than transgenic overexpression of NF-kB.
Importantly, transgenic overexpression does not allow
mimicking of the quantitative aspects of NF-kB activationand, in addition, may produce misleading results because
of gene-insertion artifacts. IkbaD/D mice were born with
Mendelian frequencies, and the Ikba allele was properly
and ubiquitously deleted (IkbaD/D) (Rupec et al., 2005).
Skin from newborn IkbaD/D mice was inconspicuous com-
pared to skin from wild-type mice (Figure S1 in the Supple-
mental Data available online). Three days after birth, 100%
of mutant mice started to develop generalized skin inflam-
mation, characterized by erythematous thickening and
scaling. The severity of the disease increased until day
7 or 8 after birth when IkbaD/D mice died. Histological anal-
ysis of skin samples from 6-day-old IkbaD/D mice revealed
epidermal hyperplasia (acanthosis), a thickened cornified
layer (hyperkeratosis), foci of nucleus-containing keratino-
cytes (parakeratosis), loss of the granular layer (hypogra-
nulosis), T cell infiltration, and the formation of microab-
scesses, all hallmarks of the epidermal changes that
characterize psoriasis. Dermal blood vessels were dilated,
and infiltrating mononuclear and polymorphonuclear cells
accumulated in the upper dermis (Figure 1A). Increased
Ki67 expression indicated a large number of proliferating
keratinocytes in comparison with mice bearing floxed
Ikba alleles (Ikbaf/f mice; Figure 1B). Immunohistochemis-
try with markers of keratinocyte proliferation and differen-
tiation revealed increased expression of keratin 6 (K6) in
the entire epidermis, reduction of loricrin, and broadening
of the keratin 5 (K5) and keratin 10 (K10) expressing kera-
tinocyte layers in the epidermal compartment of IkbaD/D
mice (Figure 1C). Assessment of skin permeability with
the toluidine blue and acidic X-Gal staining showed no
increase in dye penetration in IkbaD/D mice, suggesting
no disturbance of the ‘‘outside-in’’ epidermal barrier
(Figure S2). All these findings seem to be a direct conse-
quence of Ikba deletion in IkbaD/D mice because RelA
and p50 containing NF-kB dimers were constitutively ac-
tive in primary keratinocytes (Figures 1D and 1E). In addi-
tion, CD54, a typical target gene induced by NF-kB activa-
tion, was strongly expressed in the epidermis of IkbaD/D
mice (Figure 1F). Other NF-kB regulated genes that were
induced in the IkBa-deficient epidermis are Cxcl2,
Ccl20, Il1b, and Mmp9, Ccl20, Ccl5, and Il1b in the
IkBa-deficient dermis (Figure S3). Importantly, aberrant
NF-kB activation did not result in altered in vitro prolifera-
tion of keratinocytes, indicating that the hyperproliferation
observed in vivo was not cell autonomous in IkBa-
deficient keratinocytes (Figure 1G).
Epidermis-Specific Ikba Deletion Causes
Selective Keratinocyte Proliferation
To analyze whether epidermis-specific activation of NF-
kB is sufficient for induction of the psoriasis-like skin dis-
ease, we crossed the Ikbaf/f mice with keratin5-cre2 mice
to generate mice with epidermis-specific deletion of Ikba
(IkbaK5D/K5D) (Figure S4). IkbaK5D/K5D pups were born at
the expected Mendelian ratios and were macroscopically
indistinguishable from wild-type littermates until day 3.
Similar to IkbaD/D mice, IkbaK5D/K5D mice were growth
retarded. On day 3, 100% of IkbaK5D/K5D mice developed
a skin disease that predominantly improved by week 3.Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc. 297
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RelA Coordinates Inflammatory Skin Disease in IkBa-Deficient MiceFigure 1. Inflammatory Skin Phenotype of IkbaD/D Mice
(A) Skin sections from 6-day-old IkbaD/D mice and Ikbaf/f mice were stained with hematoxylin and eosin (320).
(B) Analysis of cell proliferation by staining skin sections from 6-day-old IkbaD/D mice and Ikbaf/f mice for Ki67 (green); red staining shows nuclei.298 Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc.
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RelA Coordinates Inflammatory Skin Disease in IkBa-Deficient MiceHistopathology of day-6 skin sections revealed a picture
different from that of IkbaD/D mice. As expected, the
epidermis of IkbaK5D/K5D mice was thickened with acan-
thosis, hyperkeratosis, and enhanced Ki67 expression
(Figures 2A and 2B). Yet, in sharp contrast to IkbaD/D
mice, IkbaK5D/K5D mice had an intact granular layer, no
parakeratosis, and no epidermal infiltration of immune
cells, and also had no microabscesses (Figure 2A). Con-
stitutive activation of NF-kB in IkbaD/D and IkbaK5D/K5D
mice was also demonstrable by phosphorylation of the
transactivating subunit RelA at Ser536 (Figure 2C). Integ-
rin b1 was strongly upregulated in the skin of IkbaD/D mice
compared to IkbaK5D/K5D and wild-type mice (Figure 2D).
Importantly, the differentiation marker K6 was absent
from the interfollicular epidermis of IkbaK5D/K5D mice
(Figure 2E). Because the K6 promoter contains elements
responsive to IL-1b (Komine et al., 2001), which plays a
putative role in the pathogenesis of psoriasis, we analyzed
IL-1b expression by real-time PCR. Although the keratino-
cyte-derived chemokines macrophage inflammatory pro-
tein-2 (MIP-2) and the keratinocyte-derived chemokine
(KC) weresimilarly expressed in both IkbaD/Dand IkbaK5D/K5D
mice, the K6-inducing cytokine IL-1b as well as IFN-g, a
cytokine putatively involved in the pathogenesis of
psoriasis (Austin et al., 1999; Nestle et al., 1994; Robert
and Kupper, 1999), were strongly induced in the dermis
of IkbaD/D mice but at background amounts in IkbaK5D/K5D
mice (Figures 2F and 2G). We found no significant differ-
ence in the expression of IL-1a and TNF when we com-
pared IkbaD/D and IkbaK5D/K5D mice (data not shown). In
addition, targeted deletion of TNF in an IkBa-deficient
background revealed no normalization of K6 expression.
This implicates that TNF is not involved in K6 regulation
(Figure S10). These results demonstrate that selective
deletion of Ikba in keratinocytes can induce abnormal pro-
liferation of keratinocytes in vivo without inducing epider-
mal inflammationand contrastswith the IkbaD/Dmice where
granulocytes and T cells were present in the epidermis.
Epidermal Involvement in Cutaneous Inflammation
Requires IkBa-Deficiency in Keratinocytes
and T Cells
Immunostaining of immune cells in skin from IkbaD/D mice
and IkbaK5D/K5D mice demonstrated increased numbers of
CD4+ and CD8+ T cells, Gr-1+ neutrophils, and macro-
phages in the dermal compartment of both IkbaD/D and
IkbaK5D/K5D mice (Figure 3A). Comparing IkbaD/D to
IkbaK5D/K5D mice clearly revealed that immune cells did
not infiltrate the epidermis and remained restricted to
the dermal compartment in IkbaK5D/K5D mice, where
CD8+ T cells and Gr-1+ neutrophils infiltrated the epider-mis of IkbaD/D mice. CD4+ cells infiltrated the skin of
IkbaD/D mice with an average of 57/1.6 mm2 and infiltrated
the skin of IkbaK5D/K5D mice with an average of 97/1.6 mm2.
CD8+ cells infiltrated the skin of wild-type mice with an
average of 7/1.6 mm2, the skin of IkbaD/D mice with an
average of 122/1.6 mm2, and the skin of IkbaK5D/K5D mice
with an average of 160/1.6 mm2. F4/80 positive cells infil-
trated the skin of wild-type mice with an average of 29/
1.6 mm2, the skin of IkbaD/D mice with an average of 75/
1.6 mm2, and the skin of IkbaK5D/K5D mice with an average
of 75/1.6 mm2. Gr-1-positive cells infiltrated the skin of
IkbaD/D mice with an average of 47/1.6 mm2 and the skin
of IkbaK5D/K5D mice with an average of 35/1.6 mm2. Be-
cause cytokines released within the dermis strongly affect
proliferation and differentiation of keratinocytes within the
epidermal compartment, we crossed IkbaD/D mice with
recombination-activating gene 2 (Rag2)-deficient mice
(Rag2/ mice). IkbaD/D Rag2/ mice remained macro-
scopically and histopathologically normal (Figure 3B and
Figure S5; data not shown), showing that activated
T and B cells are required for the enhanced keratinocyte
proliferation observed in IkbaD/D and IkbaK5D/K5D mice.
To investigate whether lymphocytes are also necessary
for the maintenance of the disease, we grafted skin from
6-day-old IkbaD/D, IkbaK5D/K5D, or control mice onto
Rag2/ mice. Four weeks later, grafts were analyzed
microscopically. No difference was detected among
IkbaD/D, IkbaK5D/K5D, and control grafts, suggesting that
IkBa-deficient T and B cells were essential for disease
maintenance (Figure 3C).
Because skin from IkbaD/D mice remained healthy when
transplanted onto Rag2/ mice, we next crossed Ikbaf/f
mice with lck-cre mice to generate IkbalckD/lckD mice
(Hennet et al., 1995). This resulted in complete deletion
of Ikba in T cells only (Figure S6). Skin of 6-day-old
IkbalckD/lckD mice was normal and did not reveal any differ-
ence as compared to that of control (Ikbaf/f) mice
(Figure 3D; Figures S7 and S8). Similarly, IkbamyD/myD
mice with IkBa deletion that is in neutrophils and macro-
phages and that results from crossing of IkbaD/D with
LysM-cre mice (Clausen et al., 1999), and IkBa-deficient
fetal liver cell chimeras (IkbaFLD/FLD) (Rupec et al., 2005),
had a macroscopically and histologically normal skin
phenotype (data not shown). We found no alterations in
the expression of epidermal differentiation markers in
IkbalckD/lckD, IkbamyD/myD, and IkbaFLD/FLD (data not shown).
In sharp contrast to the IkBa mutations affecting immune
cells only, concomitant deletion of Ikba specifically in ker-
atinocytes and T cells (IkbaK5D/K5D lckD/lckD) resulted in
a phenotype that was undistinguishable from that ob-
served in IkbaD/D mice (Figures 2D, 3E, and 3F).(C) Immunostaining of skin sections from 6-day-old IkbaD/D mice and Ikbaf/f mice for the indicated epidermal proliferation markers (green staining).
(D and E) NF-kB binding activity from primary keratinocytes was measured by gel mobility-shift analysis (D) and specified for NF-kB subunits by ELISA
(E). Bar graphs show mean ± SD, n = 4.
(F) Immunostaining of skin sections from 6-day-old IkbaD/D and control mice with a CD54 antibody for detection of ICAM-1 expression.
(G) Growth curves of primary keratinocytes in culture. A total of 30,000 cells isolated from IkbaD/D (red circles) and wild-type mice (blue squares) were
seeded per well, cultured for 7 days, and collected at different time points. Results are the mean (±SD) of cell numbers determined in cultures from
three mice.Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc. 299
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RelA Coordinates Inflammatory Skin Disease in IkBa-Deficient MiceFigure 2. Epidermis-Specific Knockout of IkBa
(A) Skin sections from 6-day-old IkbaK5D/K5D mice and Ikbaf/f mice were stained with hematoxylin and eosin (320).
(B) Analysis of cell proliferation by staining skin sections from 6-day-old IkbaK5D/K5D mice and Ikbaf/f mice for Ki67 (green); red staining shows nuclei.
(C) Immunostaining of skin section from 6-day-old IkbaD/D, IkbaK5DK5D, and IkbaK5D/K5D lckD/lckD mice and control mice with a specific antibody against
RelA phosphorylated at Ser536. Nuclear staining is shown in the insets.
(D) Immunostaining of skin sections from 6-day-old IkbaD/D, IkbaK5DK5D, and control mice with a specific antibody against integrin b1. Red counter-
staining shows nuclei.300 Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc.
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RelA Coordinates Inflammatory Skin Disease in IkBa-Deficient MiceThus, although the presence of both lymphocytes and
polymorphonuclear leukocytes is required for the inflam-
matory skin disease, loss of IkBa from immune cells alone
is not sufficient for disease initiation. Together, the data
strongly suggest that simultaneous IkBa deficiency in
both the epidermal compartment and the immune system
is needed for initiation and maintenance of this inflamma-
tory disease of the skin.
Skin Inflammation Depends on TNF and LT
Inflamed tissue is characterized by a local milieu main-
tained by the production of proinflammatory cytokines.
Tumor necrosis factor (TNF), lymphotoxin (LT)a, and LTb
are NF-kB-regulated key mediators of inflammation
(Aggarwal, 2003). Serum TNF was under a detectable
amount in control mice and strongly increased in IkbaD/D
mice (Figure 4A). We inhibited TNF signaling by crossing
IkbaD/D mice with either TNF receptor 1 (TNFR1)-deficient
(Pfeffer et al., 1993) (IkbaD/D Tnfrsf1a/) or TNF-deficient
(Pasparakis et al., 1996) (IkbaD/D Tnf/) mice. We
inhibited LTa signaling by crossing IkbaD/D mice with
LTa-deficient (De Togni et al., 1994) (IkbaD/D Lta/)
mice. In all three double-deficient mice, inflammation
was reduced but still clearly detectable, pointing to the
involvement of TNF-independent proinflammatory path-
ways (Figure 4 C and Figures S9 and S10; data not
shown). Next, we crossed IkbaD/D mice with TNF-LTD3
mice, which are deficient for TNF, LTa, and LTb (Kuprash
et al., 2002) (IkbaD/D TNF-LTD3 mice). The skin of these
animals showed no signs of inflammation and had an
entirely normal phenotype (Figure 4C and Figure S10),
demonstrating that the inflammatory disease resembling
psoriasis was dependent on TNF and LT signaling.
Epidermal RelA Coordinates Epidermal-Dermal
Cell Interactions
The transactivating NF-kB subunit identified in IkbaD/D and
IkbaK5D/K5D keratinocytes was RelA. To directly analyze
the contribution of RelA to the development of the inflam-
matory skin phenotype in IkbaD/D and IkbaK5D/K5D mice, we
generated mice carrying LoxP site-containing RelA alleles
(Relaf/f). These were crossed with keratin5-cre2 mice for
obtaining mice with epidermis-specific deletion of RelA
(Figure S12). Mice with epidermis-specific deletion of
Rela (RelaK5D/K5D) were phenotypically inconspicuous.
Neither skin sections from 5-day-old nor skin sections
from 4-month-old RelAK5D/K5D mice showed any signs of
abnormal epidermis differentiation or proliferation, when
compared to Relaf/f or wild-type controls (Figure 5A). As
a consequence, the expression pattern of skin differentia-
tion markers was identical to that of control skin (Fig-
ure S13). When backcrossed to IkbaD/D mice, IkbaD/D
RelaK5D/K5D double-mutant mice, with ubiquitous deletionof Ikba and epidermis-specific deletion ofRela, did not de-
velop the inflammatory skin disease (Figures 5B and 5C).
These mice exhibited no differences in the expression of
epidermal differentiation markers compared to wild-type
mice (Figure S13). Interestingly, deletion of only one Rela
allele strongly improved but did not abolish the phenotype
of IkbaD/D mice. Mice deficient for IkBa and heterozygous
for the epidermis-specificRelamutation, IkbaD/DRela+/K5D,
showed hyperkeratotic, scaly, and inflamed skin only
at sites exposed to mechanical friction (data not shown),
similarly to Koebner’s phenomenon in psoriatic individuals.
Thus, epidermal RelA expression was crucial for initia-
tion and maintenance of the inflammatory skin disease in
IkBa-deficient mice.
DISCUSSION
The data presented here show that simultaneous activa-
tion of NF-kB in immune cells and in keratinocytes is
sufficient for the induction of a persistent skin inflamma-
tion that shares many similarities with human psoriasis.
NF-kB activation by selective deletion of IkBa either in
the epidermis or in immune cells alone did not give rise
to the full inflammatory skin phenotype. The skin disease
required concomitant IkBa deletion in keratinocytes and
lymphocytes and was strictly dependent on signaling
through cytokines of the TNF superfamily, a feature
shared with autoimmune diseases such as psoriasis or
rheumatoid arthritis. Importantly, targeted deletion of
RelA in keratinocytes of double-transgenic IkbaD/D
RelaK5D/K5D mice prevented disease development and
demonstrated that aberrant signaling through RelA within
the epidermis was essential for the development of the
inflammatory skin disease.
Various transgenic and knockout mice have been
generated that mimic aspects of inflammatory diseases
at body surfaces such as the skin (Cheng et al., 1992),
IFN-g (Carroll et al., 1997), integrins (b1, a2b1, a5b1) (Car-
roll et al., 1995), Stat3 (Sano et al., 2005), and others (Nick-
oloff and Wrone-Smith, 1997; Scho¨n, 1999). Many of
these mutations directly or indirectly modulate NF-kB
activity. In most models, investigations into disease mech-
anisms have been restricted to either the skin or the
immune system. Here, we asked whether a disturbed
crosstalk between keratinocytes and immunocytes is
causal for the inflammatory process already at its initiation.
By evaluating contributions of various tissue compart-
ments to disease development, we show that epidermis-
specific targeting of Ikba results in keratinocyte hyper-
proliferation, but without inflammation in the epidermal
compartment. The infiltration of the epidermis by inflam-
matory cells might involve integrin b1 because we found(E) Immunostaining of skin sections from 6-day-old IkbaK5D/K5Dmice and Ikbaf/f mice for the indicated epidermal differentiation marker (green staining).
(F and G) Induction of the indicated genes in the skin of 6-day-old IkbaD/D and IkbaK5D/K5D mice was measured by real-time RT-PCR with RNA samples
prepared from six different IkbaD/D and IkbaK5D/K5Dmice. Triplicate determination was performed for each mRNA sample. Gene-expression levels were
normalized with tubulin for each mRNA preparation, and the n-fold increase in IkbaD/D and IkbaK5D/K5D mice was calculated by comparison with the
result obtained in wild-type mice. Results are the mean (±SD) of seven mice.Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc. 301
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RelA Coordinates Inflammatory Skin Disease in IkBa-Deficient MiceFigure 4. Requirement of TNF and LT for
the Development of the Skin Phenotype
in Ikba D/D Mice
(A) Analysis of the TNF serum concentration in
6-day-old IkbaD/D, IkbaK5D/K5D, and control
mice. ELISA data of one representative exper-
iment (of three repeated experiments) are
presented.
(B) Skin sections from 7-day-old IkbaD/D
Tnf/, IkbaD/D Lta/, and Ikba+/+ Tnf/ mice.
(C) Skin sections from 5-day-old IkbaD/D and
IkbaD/D TNF-LTD3 mice were stained with
hematoxylin and eosin.upregulated expression of this adhesion molecule in
IkbaD/D mice in contrast to IkbaK5D/K5D and wild-type
mice. Hyperproliferation of keratinocytes in vivo depends
on the presence of lymphocytes in the skin, is due to the
inflammatory tissue milieu, and is not cell autonomous
because an ex vivo proliferation assay revealed no differ-
ence in the growth of IkbaD/D keratinocytes compared to
wild-type keratinocytes.
Cell-cycle regulation in keratinocytes seems to be inde-
pendent from intrinsic RelA activity because wild-type andIkbaD/D keratinocytes showed identical proliferative be-
havior in vitro, although NFkB signaling was constitutively
active in the latter. This is further supported by the normal
skin phenotype of mice with epidermis-specific deletion of
Rela. The discrepancy in comparison to previously pub-
lished results (Zhang et al., 2004), demonstrating hyper-
proliferation in RelA deficient skin, may be due to the dif-
ferent experimental approach.
The central role of RelA signaling in keratinocytes for
disease induction was most strikingly demonstrated byFigure 3. Inflammation in the Skin of IkbaD/D and IkbaK5D/K5D Mice and IkbaK5D/K5D lckD/lckD Mice
(A) Skin sections from 6-day-old IkbaD/D, IkbaK5D/K5D, and control mice were immunostained with antibodies recognizing T cells (CD4 and CD8), mac-
rophages (F4/80) and neutrophilic granulocytes (Gr-1) (green signal). The inset in the CD8 staining of skin from IkbaD/D mice shows positive cells in the
epidermal layer. Red counterstaining shows nuclei.
(B–D) Skin sections from 6-day-old IkbaD/D Rag2/ mice, IkbaD/D skin transplanted onto Rag2/ mice (IkbaD/D Tx Rag2/), IkbaK5D/K5D skin trans-
planted onto Rag2/ mice (IkbaK5D/K5D Tx Rag2/), 6-day-old IkbalckD/lckD mice, and control mice were stained with hematoxylin and eosin.
(E) Skin sections from 7-day-old IkbaK5D/K5D lckD/lckD and control mice were stained with hematoxylin and eosin and immunostained for the indicated
epidermal differentiation marker (green staining).
(F) Skin sections from 7-day-old IkbaK5D/K5D lckD/lckD and control mice were immunostained with antibodies recognizing T cells (CD3), macrophages
(F4/80), and neutrophilic granulocytes (Gr-1) (green signal).Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc. 303
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RelA Coordinates Inflammatory Skin Disease in IkBa-Deficient MiceFigure 5. The Skin Phenotype in IkbaD/D Mice Depends on Epidermal RelA Expression
(A) Skin sections from 5-day-old and 16-week-old RelaK5D/K5D and control mice were stained with hematoxylin and eosin.
(B and C) Staining of skin sections from 6-day-old IkbaD/D RelaK5D/K5D and control mice were stained with hematoxylin and eosin (B) or antibodies
against the indicated immune cell markers (C). Red counterstaining shows nuclei.double knockout animals that have ubiquitous deletion of
IkBa and epidermis-specific deletion of RelA and that
showed a normal phenotype. This is in line with the obser-
vation that skin inflammation is absent in mice with spe-
cific deletion of IkBa in immune cells only (IkbalckD/lckD,
IkbamyD/myD, and IkbaFLD/FLD) and highlights the important
pathogenic role of the epithelium. By using several differ-
ent approaches, we here demonstrate a functional, path-
ogenic cooperation that is mediated by RelA between
keratinocytes and immune cells. The exact pathogenic
steps that link RelA activation in keratinocytes to T cell
infiltration still remain open, although production of che-
motactic factors such as S100A8, S100A9, KC, and304 Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc.MIP-2 and increased expression of integrinb1 are likely
to be of relevance.
TNF blockers have recently been introduced into the
treatment of inflammatory diseases such as psoriasis
(Koo and Khera, 2005). We provide genetic evidence
that, in addition to TNF and TNFR1 signaling, LTs may be
important mediators in the pathogenesis of psoriasis.
LTa forms homotrimers with signaling through TNFR1
and TNFR2 and forms heterotrimers with LTb signaling
through LTbR (Pfeffer, 2003). Only in a triple-knockout
deficient for Tnf, Lta, and Ltb was the development of the
skin phenotype efficiently inhibited, whereas it was signif-
icantly attenuated in single knockouts for either Tnfrsf1a or
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proach in which LTs are inhibited in addition to TNF.
Our results show that RelA activity in keratinocytes is
required for initiation of the inflammatory skin phenotype
after ablation of IkBa. At first glance, this may seem sur-
prising because IKK2 deletion that causes an inhibition
of NF-kB activation produces a phenotype similar to that
observed in IkbaD/D mice (Pasparakis et al., 2002). Our
analyses revealed, however, that the mechanisms leading
to these two skin conditions differ fundamentally in their
T cell dependence. This suggests that skin homeostasis
requires balanced NF-kB activity: Constitutive activation
of NF-kB will lead to a T cell-dependent inflammatory
skin disease, whereas inhibition of NF-kB activation
results in T cell-independent skin inflammation.
In summary, we have characterized pathogenic interac-
tions between epithelial cells covering a body surface and
immune cells. We believe that this model gives novel
insight into the pathogenesis of inflammatory skin
diseases but could also be of relevance to inflammatory
conditions of other body surfaces, such as the gut and
the urinary tract.
EXPERIMENTAL PROCEDURES
Generation of IkbaD/D, IkbaK5D/K5D, IkbalckD/lckD, IkbamyD/myD,
and RelaK5D/K5D Mice
Mice carrying a floxed Ikba allele (Ikbaf/f) (Rupec et al., 2005) were
crossed with Deleter-cre mice (Schwenk et al., 1995) (IkbaD/D) and
with transgenic mice expressing Cre recombinase under the control
of the keratinocyte-specific keratin5 promoter (Tarutani et al., 1997)
(IkbaK5D/K5D), T cell-specific lck promoter (Hennet et al., 1995)
(IkbalckD/lckD), and neutrophil and macrophage-specific LysM promoter
(Clausen et al., 1999) (IkbamyD/myD), respectively. To obtain IkbaD/D
RelaK5D/K5D mice, we crossed offspring of Relaf/f (Algu¨l et al., 2007)-
K5-cre2 intercross with IkbaD/D mice. We generated IkbaD/D Rag2/
mice, IkbaD/D TNF-LTD3 mice, and IkbaD/D Tnfrsf1a/and IkbaD/D
Tnf/mice by breeding IkbaD/D mice into the respective backgrounds.
The genetic background was C57BL/6 for Ikbaf/f, Relaf/f, K5-cre2,
LysM-cre, lck-cre, Rag2/, Tnfrsf1a/, Tnf/, Lta/, and TNF-
LTD3 mice.
PCR
Mice were genotyped by PCR (sequence available upon request);
expected sizes of the PCR products are for the Ikba gene 340 bp for
the floxed allele, 250 bp for the wild-type allele, and 500 bp for the
deleted allele. For the Rela gene, the expected sizes are 294 bp for
the floxed allele, 260 bp for the wild-type allele, and 400 bp for the
deleted allele.
Histology and Immunohistochemistry
Skin samples were fixed in 4% formaldehyde for 24 hr and embedded
in paraffin, and 5 mm serial sections were stained with hematoxylin and
eosin (H and E). Phosphorylated RelA was detected with antiphospho-
p65 (Cell Signaling Technology). For frozen sections, skin samples
taken from the back were snap frozen in 2-methylbutane (Merck)
and embedded in OCT Tissue Tec Media (Miles). Five-micrometer
sections were cut with a Cryotom (Leica), taken up in 4% PBS, and
rinsed with water. Antibodies against CD31 and CD54 (R & D Systems)
were used together with the biotin-streptavidin detection system
(Vector Systems). ABC-system block and the Avidin-Biotin-Block
(DAKO) were used when appropriate. For visualization of antibody
binding, AEC (Sigma) was applied until the desired color intensity
developed. After washing in H2O, sections were counterstained withhematoxylin and mounted with Aquatex (Merck). Staining of inflamma-
tory and proliferating cells was performed as described previously
(Pasparakis et al., 2002). The following rat monoclonal antibodies
were used on frozen sections: anti-CD3 and -CD8 (both 1:1000; Chem-
icon), anti-CD4 (1:50; BD Biosciences PharMingen), and Ki-67 (1:50;
clone TEC-3, Dako).
Outside-In Barrier Assays
For Toluidine blue staining, newborn mice were killed, bathed in meth-
anol for 5 min, and, after a washing step with PBS, incubated for 15 min
in 0.1% Toluidine blue (Sigma). For acidic X-Gal staining, newborn
mice were killed, rinsed with water, and incubated in 4 mM
K3Fe(CN)6, 4 mM K4Fe(CN)6, 2 mM MgCl2, 1 mg/ml 5-Bromo-
4-chloro-3-indolyl b-D-galactopyranoside (Sigma), and 0.1 M KH2PO4
at pH 4.5, at 30C for 6 hr.
Electrophoretic Mobility-Shift Assay and NF-kB ELISA
Electrophoretic mobility shift assays were performed as described
previously (Rupec et al., 2005). The NF-kB ELISA was performed
according to the instructions of the manufacturer (Active Motif).
Isolation and Culture of Mouse Keratinocytes and T Cells
Keratinocytes were isolated from the skin of newborn mice as de-
scribed (Roper et al., 2001) and cultured in collagen type IV-coated
plates in SFM keratinocyte medium (GIBCO) on feeder cells. Cells
were resuspended at 1 3 106 per 100 ml of PBS containing 1% FCS,
pretreated with Fc-block (anti-CD16/anti-CD32, PharMingen), and
stained for 30 min at 4C with the indicated mouse antibodies. Viable
cells, as determined by forward and side scatter profiles, were sorted
with a MoFlo Sorter (Cytomation).
Skin Grafts
We surgically transplanted skin from 6-day-old Ikba D/D, Ikba K5D/K5D,
and control mice into the dorsal region of 7- to 8-week-old anaesthe-
tized Rag2/ mice. The average size of donor grafts was 1–1.5 cm
diameter. The grafts were dressed with Jelonet* gaze (Smith +
Nephew) and Fixomull stretch (BSN medical) bandage. After 10–12
days, the bandages were removed. For Ikba D/D and Ikba K5D/K5D grafts,
the donor origin was verified by PCR with RNA isolated from keratino-
cytes.
RT-PCR
Total RNA was isolated from cultured keratinocytes or from full skin by
the Trizol protocol (GIBCO/BRL). Total RNA was digested with DNase I
(Sigma) for removal of DNA contamination and reverse-transcribed
with SuperScript II according to the manufacturer’s instructions
(GIBCO/BRL). PCR amplifications were performed with the primers
according to standard methods. Primer sequences are available
upon request.
TNF ELISA
For determination of TNF levels in murine serum, an ELISA kit (Quanti-
kine, R & D systems) was used according to the instructions of the
manufacturer.
cDNA Libraries and Processing of Microarrays
cRNA preparation was performed with the Illumina TotalPrep RNA
Amplification Kit (Ambion Europe) according to the manufacturer’s
instructions. cRNA (1.5 mg) was hybridized to Sentix Mouse-6 Expres-
sion Beadchips (Illumina) and scanned on Illumina BeadStation 5003.
For data collection and analysis, Illumina BeadStudio and dChip 1.3
software were used.
Supplemental Data
Thirteen figures are available at http://www.immunity.com/cgi/
content/full/27/2/296/DC1/.Immunity 27, 296–307, August 2007 ª2007 Elsevier Inc. 305
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